| Application no. and date | 08742061.8 (espacenet) (Federated) (European Patent Register), 20080311 | | Patent/reg. no. and date | DK/EP 2121989, 20140122 | | Publication date | 20091125 | | Priority no. and date | US 906943 P, 20070313 | | EP pub. no. and date |
EP 2121989 20091125 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | P063759DK | | Inventor | JUAN, Todd, 4629 Calle San Juan
Newbury Park, CA 91320, US,
FREEMAN, Daniel, 942 Grayrock Street
Newbury Park, CA 91320, US,
RADINSKY, Robert, 3574 Lang Ranch Parkway
Thousand Oaks, CA 91362, US | | Representative | LARSEN & BIRKEHOLM A/S SKANDINAVISK PATENTBUREAU, Bredgade 3, 3., 1260 København K | | Opponent | | | IPC Class | C12Q 1/68 (2018.01) , G01N 33/574 (2006.01) | | Title | K-ras-mutationer og anti-EGFR-antistofbehandling | | Int. application no. | US2008003312 | | Int. publication no. | WO2008112269 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
